Differential poisoning of human and Aspergillus nidulans DNA topoisomerase I by bi- and terbenzimidazoles

被引:18
作者
Goldman, GH
Yu, C
Wu, HY
Sanders, MM
LaVoie, EJ
Liu, LF
机构
[1] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT PHARMACOL,PISCATAWAY,NJ 08854
[2] RUTGERS STATE UNIV,DEPT PHARMACEUT CHEM,PISCATAWAY,NJ 08854
关键词
D O I
10.1021/bi963033t
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA topoisomerase I has been partially purified from Aspergillus nidulans. The purified enzyme is most likely the major nuclear DNA topoisomerase I on the basis of the following findings. (1) Purified DNA topoisomerase I can relax both positively and negatively supercoiled DNA. (2) Neither an energy cofactor nor Mg(II) is required for the relaxation or the cleavage reaction of the enzyme. On the basis of a phosphate-transfer experiment, the Aspergillus topoisomerase I was shown to have a molecular mass (M-r) of 105 kDa. The differential sensitivity of the human and Aspergillus topoisomerase I was compared using a number of known human DNA topoisomerase I poisons. Like human DNA topoisomerase I, Aspergillus topoisomerase I is highly sensitive to the poisoning activity of camptothecin and a number of bi- and terbenzimidazoles. However, unlike human topoisomerase I, Aspergillus topoisomerase I is completely resistant to monobenzimidazoles, protoberberines (e.g. coralyne), and nitidine. Cytotoxicity studies using yeast expressing human and yeast topoisomerase I cDNAs have also demonstrated a similar differential sensitivity of yeast topoisomerase I to these human topoisomerase I poisons. These results together suggest that the nuclear fungal topoisomerase I may be sufficiently different from its human counterpart to serve as a molecular target for the development of antifungal drugs.
引用
收藏
页码:6488 / 6494
页数:7
相关论文
共 36 条
  • [1] CHARACTERIZATION OF A MAMMALIAN MUTANT WITH A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I
    ANDOH, T
    ISHII, K
    SUZUKI, Y
    IKEGAMI, Y
    KUSUNOKI, Y
    TAKEMOTO, Y
    OKADA, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) : 5565 - 5569
  • [2] BJORNSTI MA, 1989, CANCER RES, V49, P6318
  • [3] DNA MINOR GROOVE-BINDING LIGANDS - A DIFFERENT CLASS OF MAMMALIAN DNA TOPOISOMERASE-I INHIBITORS
    CHEN, AY
    YU, C
    GATTO, B
    LIU, LF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) : 8131 - 8135
  • [4] IDENTIFICATION OF THE AMINOCATECHOL A-3253 AS AN IN-VITRO POISON OF DNA TOPOISOMERASE-I FROM CANDIDA-ALBICANS
    FOSTEL, J
    MONTGOMERY, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) : 586 - 592
  • [5] CHARACTERIZATION OF DNA TOPOISOMERASE-I FROM CANDIDA-ALBICANS AS A TARGET FOR DRUG DISCOVERY
    FOSTEL, JM
    MONTGOMERY, DA
    SHEN, LL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) : 2131 - 2138
  • [6] Gatto B, 1996, CANCER RES, V56, P2795
  • [7] HSIANG YH, 1985, J BIOL CHEM, V260, P4873
  • [8] SYNTHESIS AND EVALUATION OF NEW 6-AMINO-SUBSTITUTED BENZO[C]PHENANTHRIDINE DERIVATIVES
    JANIN, YL
    CROISY, A
    RIOU, JF
    BISAGNI, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (23) : 3686 - 3692
  • [9] JAXEL C, 1991, J BIOL CHEM, V266, P20418
  • [10] Substituted 2,5'-bi-1H-benzimidazoles: Topoisomerase I inhibition and cytotoxicity
    Kim, JS
    Gatto, B
    Yu, C
    Liu, A
    Liu, LF
    LaVoie, EJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) : 992 - 998